Ligand profile
CHEMBL5983321
Bioactivity hit from ChEMBL on a similar protein.
Bound to: KP13_00976 — 2-succinyl-6-hydroxy-2, 4-cyclohexadiene-1-carboxylate synthase
Identifiers
Database identifiers and provenance.
- Ligand ID
CHEMBL5983321- UniProt (similar protein)
Q9BV23- pchembl
- 7.260 (~55.0 nM)
- Target protein
- KP13_00976
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 49.8
- −1 ≤ LogP ≤ 5 3.34
- MW ≤ 500 Da 329.2
- LogP ≤ 5 3.34
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 3
- Rotatable bonds ≤ 10 1
- TPSA ≤ 140 Ų 49.8
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
O=C(OC(C(F)(F)F)C(F)(F)F)N1Cc2ccc(O)cc2C1O=C(OC(C(F)(F)F)C(F)(F)F)N1Cc2ccc(O)cc2C1
InChI=1S/C12H9F6NO3/c13-11(14,15)9(12(16,17)18)22-10(21)19-4-6-1-2-8(20)3-7(6)5-19/h1-3,9,20H,4-5H2InChI=1S/C12H9F6NO3/c13-11(14,15)9(12(16,17)18)22-10(21)19-4-6-1-2-8(20)3-7(6)5-19/h1-3,9,20H,4-5H2
FERFZVBNCNAAGL-UHFFFAOYSA-NFERFZVBNCNAAGL-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- ChEMBL
- Activity
- 906495
- Binding sites
- PF00561
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ChEMBL ChEMBL compound CHEMBL5983321 →
- UniProt UniProt Q9BV23 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CHEMBL5983321”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_00976.
ChEMBL 99
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).